Piotr Czaykowski

3.7k total citations · 1 hit paper
89 papers, 2.2k citations indexed

About

Piotr Czaykowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Piotr Czaykowski has authored 89 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 44 papers in Pulmonary and Respiratory Medicine and 22 papers in Surgery. Recurrent topics in Piotr Czaykowski's work include Renal cell carcinoma treatment (19 papers), Prostate Cancer Treatment and Research (13 papers) and Colorectal Cancer Screening and Detection (11 papers). Piotr Czaykowski is often cited by papers focused on Renal cell carcinoma treatment (19 papers), Prostate Cancer Treatment and Research (13 papers) and Colorectal Cancer Screening and Detection (11 papers). Piotr Czaykowski collaborates with scholars based in Canada, United States and India. Piotr Czaykowski's co-authors include Daniel A. Vaena, Walter M. Stadler, Eric J. Small, Jonathan E. Rosenberg, Susan Halabi, Janice P. Dutcher, Joel Picus, Brian I. Rini, Ian F. Tannock and Laura Archer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Piotr Czaykowski

83 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

2008 707 citations Piotr Czaykowski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Piotr Czaykowski Canada	23	1.2k	857	796	604	440	89	2.2k
Monique M.E.M. Bos Netherlands	19	667 0.6×	1.1k 1.3×	527 0.7×	407 0.7×	203 0.5×	36	2.1k
A. Garin Russia	10	1.2k 1.0×	777 0.9×	644 0.8×	422 0.7×	538 1.2×	26	1.9k
Georg C. Hutterer Austria	34	1.9k 1.6×	1.2k 1.5×	922 1.2×	789 1.3×	1.2k 2.8×	122	3.6k
Laura Archer United States	17	859 0.7×	527 0.6×	532 0.7×	482 0.8×	168 0.4×	27	1.5k
Andrea Veronesi Italy	28	676 0.6×	1.6k 1.9×	469 0.6×	630 1.0×	344 0.8×	135	2.8k
Sarah P. Psutka United States	29	1.7k 1.4×	761 0.9×	1.1k 1.4×	384 0.6×	1.4k 3.2×	184	3.5k
Cristina Granetto Italy	16	944 0.8×	2.4k 2.8×	285 0.4×	320 0.5×	553 1.3×	64	2.9k
Jae Moon Bae South Korea	31	2.7k 2.2×	987 1.2×	661 0.8×	360 0.6×	1.4k 3.2×	132	3.9k
Jan Schmitges Germany	24	1.6k 1.4×	615 0.7×	497 0.6×	208 0.3×	1.1k 2.4×	60	2.4k
Margit Fisch Germany	30	1.1k 0.9×	607 0.7×	574 0.7×	368 0.6×	1.6k 3.5×	129	2.9k

Countries citing papers authored by Piotr Czaykowski

Since Specialization

Citations

This map shows the geographic impact of Piotr Czaykowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Czaykowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Czaykowski more than expected).

Fields of papers citing papers by Piotr Czaykowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Czaykowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Czaykowski. The network helps show where Piotr Czaykowski may publish in the future.

Co-authorship network of co-authors of Piotr Czaykowski

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Czaykowski. A scholar is included among the top collaborators of Piotr Czaykowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Czaykowski. Piotr Czaykowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Decker, Kathleen, Oliver Bucher, Piotr Czaykowski, et al.. (2025). Measuring the Association Between the COVID-19 Pandemic and Cancer Incidence by Sex Using a Quasi-Experimental Study Design. JCO Clinical Cancer Informatics. 9(9). e2400327–e2400327. 1 indexed citations

Decker, Kathleen, Pascal Lambert, Philip St. John, et al.. (2024). Impact of age, comorbidity, and polypharmacy on receipt of systemic therapy in advanced cancers: A retrospective population-based study. Journal of Geriatric Oncology. 15(2). 101689–101689. 3 indexed citations

Lambert, Pascal, et al.. (2023). Impact of Cancer-Related Virtual Visits on Travel Distance, Travel Time, and Carbon Dioxide (CO2) Emissions during the COVID-19 Pandemic in Manitoba, Canada. Current Oncology. 30(7). 5973–5983. 3 indexed citations

Lambert, Pascal, Eric J. Bow, Piotr Czaykowski, et al.. (2023). Evaluation of the Impact of the Urgent Cancer Care Clinic on Emergency Department Visits, Primary Care Clinician Visits, and Hospitalizations in Winnipeg, Manitoba. Current Oncology. 30(7). 6771–6785. 3 indexed citations

Gibson, Ian W., et al.. (2023). Redefining Renal Cell Carcinoma: A Molecular Perspective on Classification and Clinical Implications. SHILAP Revista de lepidopterología. 116–123.

Czaykowski, Piotr, et al.. (2023). Prostate Cancer Metastasis to Stomach: A Case Report and Review of Literature. Current Oncology. 30(4). 3901–3914. 4 indexed citations

Wood, Lori, Robert J. Hamilton, Piotr Czaykowski, et al.. (2022). Testicular cancer survivorship: Long-term toxicity and management. Canadian Urological Association Journal. 16(8). 257–272. 12 indexed citations

Cheung, Patrick, Samir Patel, Scott North, et al.. (2021). Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study. European Urology. 80(6). 693–700. 82 indexed citations

Leslie, William D., Beatrice J. Edwards, Lin Yan, et al.. (2020). Cancer patients with fractures are rarely assessed or treated for osteoporosis: a population-based study. Osteoporosis International. 32(2). 333–341. 3 indexed citations

10.

Jiang, Di, Scott North, Christina Canil, et al.. (2020). Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada. Bladder Cancer. 6(3). 363–392. 2 indexed citations

11.

Warren, Mark, Michael Kolinsky, Christina M. Canil, et al.. (2019). Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma. Canadian Urological Association Journal. 13(10). 318–327. 9 indexed citations

12.

Bjarnason, Georg A., Jennifer J. Knox, Christian Kollmannsberger, et al.. (2019). The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial. European Journal of Cancer. 108. 69–77. 24 indexed citations

13.

Graham, Jeffrey, et al.. (2018). Baseline Edmonton Symptom Assessment System and Survival in Metastatic Renal Cell Carcinoma. Current Oncology. 25(4). 319–323. 11 indexed citations

14.

Lalani, Aly‐Khan A., D.Y.C. Heng, Lori Wood, et al.. (2016). Real world outcomes of patients with metastatic renal cell carcinoma (mRCC) using first-line sunitinib or pazopanib: the Canadian experience. Annals of Oncology. 27. vi285–vi285. 3 indexed citations

15.

Saad, Fred, Eric Winquist, Scott Berry, et al.. (2016). Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone. Canadian Urological Association Journal. 10(3-4). 102–102. 9 indexed citations

16.

Easaw, Jacob C., Melissa Shea‐Budgell, Chengliang Wu, et al.. (2015). Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment. Current Oncology. 22(2). 144–144. 38 indexed citations

17.

Oechsle, Karin, Friedemann Honecker, Tina Cheng, et al.. (2011). Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study. Annals of Oncology. 22(12). 2654–2660. 72 indexed citations

18.

Paulson, Kristjan, Piotr Czaykowski, C Coppin, et al.. (2010). Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study. Bone Marrow Transplantation. 46(6). 852–857. 1 indexed citations

19.

Ellard, Susan, Sébastien J. Hotte, Piotr Czaykowski, et al.. (2007). A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer. Annals of Oncology. 19(4). 746–751. 93 indexed citations

20.

Berthelet, Eric, Pauline T. Truong, Piotr Czaykowski, et al.. (2003). CT slice index and thickness: Impact on organ contouring in radiation treatment planning for prostate cancer. Journal of Applied Clinical Medical Physics. 4(4). 365–373. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact